Increased expression and function of glutamate transporters in multiple sclerosis

Arriza, 1994, Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex, J. Neurosci., 14, 5559, 10.1523/JNEUROSCI.14-09-05559.1994 Barkhatova, 1998, Changes in neurotransmitters in multiple sclerosis, Neurosci. Behav. Physiol., 28, 341, 10.1007/BF02464784 Betz, 1994, Blood–brain–cerebrospinal fluid barriers, 681 Bhat, 1996, Expression of the APC tumor suppressor protein in oligodendroglia, Glia, 17, 169, 10.1002/(SICI)1098-1136(199606)17:2<169::AID-GLIA8>3.0.CO;2-Y Chretien, 2002, Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques, Neuropathol. Appl. Neurobiol., 28, 410, 10.1046/j.1365-2990.2002.00426.x Danbolt, 2001, Glutamate uptake, Prog. Neurobiol., 65, 1, 10.1016/S0301-0082(00)00067-8 Divino Filho, 1998, Glutamate concentration in plasma, erythrocyte and muscle in relation to plasma levels of insulin-like growth factor (IGF)-I, IGF binding protein-1 and insulin in patients on haemodialysis, J. Endocrinol., 156, 519, 10.1677/joe.0.1560519 Domercq, 1999, Expression of glutamate transporters in the adult bovine corpus callosum, Brain Res. Mol. Brain Res., 67, 296, 10.1016/S0169-328X(99)00072-8 Domercq, 1999, Expression of glutamate transporters in rat optic nerve oligodendrocytes, Eur. J. Neurosci., 11, 2226, 10.1046/j.1460-9568.1999.00639.x Domercq, M., Etxebarria, E., Perez-Samartin, A., Matute, C., in press. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia May 12, (Electronic publication ahead of print). Duan, 1999, Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST, J. Neurosci., 19, 10193, 10.1523/JNEUROSCI.19-23-10193.1999 Garcia-Barcina, 1996, Expression of kainate-selective glutamate receptor subunits in glial cells of the adult bovine white matter, Eur. J. Neurosci., 8, 2379, 10.1111/j.1460-9568.1996.tb01201.x Garcia-Barcina, 1998, AMPA-selective glutamate receptor subunits in glial cells of the adult bovine white matter, Brain Res. Mol. Brain Res., 53, 270, 10.1016/S0169-328X(97)00318-5 Graumann, 2003, Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult, Brain Pathol., 13, 554, 10.1111/j.1750-3639.2003.tb00485.x Hardin-Pouzet, 1997, Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis, Glia, 20, 79, 10.1002/(SICI)1098-1136(199705)20:1<79::AID-GLIA8>3.0.CO;2-0 Kim, 2003, Transcriptional regulation of human excitatory amino acid transporter 1 (EAAT1): cloning of the EAAT1 promoter and characterization of its basal and inducible activity in human astrocytes, J. Neurochem., 87, 1485, 10.1046/j.1471-4159.2003.02128.x Lassmann, 1998, Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna, J. Neuroimmunol., 86, 213, 10.1016/S0165-5728(98)00031-9 Li, 1999, Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport, J. Neurosci., 19, RC16, 10.1523/JNEUROSCI.19-14-j0002.1999 Lin, 1998, Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis, Neuron, 20, 589, 10.1016/S0896-6273(00)80997-6 Lopez-Redondo, 2000, Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy, Brain Res. Mol. Brain Res., 76, 429, 10.1016/S0169-328X(00)00022-X Lowy, 1995, Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats, J. Neurochem., 65, 268, 10.1046/j.1471-4159.1995.65010268.x Lucchinetti, 1999, A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases, Brain, 122, 2279, 10.1093/brain/122.12.2279 Lyons, 1998, Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglucemia injury in vitro, J. Cereb. Blood Flow Metab., 18, 521, 10.1097/00004647-199805000-00007 Matsumoto, 1999, Identification of truncated human glutamate transporter, Tohoku J. Exp. Med., 187, 173, 10.1620/tjem.187.173 Matute, 1998, Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve, Proc. Natl. Acad. Sci. U. S. A., 95, 10229, 10.1073/pnas.95.17.10229 Matute, 1997, Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes, Proc. Natl. Acad. Sci. U. S. A., 94, 8830, 10.1073/pnas.94.16.8830 Matute, 2001, The link between excitotoxic oligodendroglial death and demyelinating diseases, Trends Neurosci., 24, 224, 10.1016/S0166-2236(00)01746-X Mawrin, 2003, Changes of retinal glutamate transporter GLT-1 mRNA levels following optic nerve damage, Mol. Vision, 9, 10 McDonald, 1998, Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity, Nat. Med., 4, 217, 10.1038/nm0398-291 Meyer, 1998, Alternative splicing of the glutamate transporter EAAT2 (GLT-1), Neurosci. Lett., 241, 68, 10.1016/S0304-3940(97)00973-7 Milton, 1997, Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study, Brain Res. Mol. Brain Res., 52, 17, 10.1016/S0169-328X(97)00233-7 Nakamura, 1993, Glial plasmalemmal vesicles: a subcellular fraction from rat hippocampal homogenate distinct from synaptosomes, Glia, 9, 48, 10.1002/glia.440090107 Oldendorf, 1976, Amino acid assignment to one of three blood–brain barrier amino acid carriers, Am. J. Physiol., 230, 94, 10.1152/ajplegacy.1976.230.1.94 Piani, 1991, Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate, Neurosci. Lett., 133, 159, 10.1016/0304-3940(91)90559-C Pitt, 2000, Glutamate excitotoxicity in a model of multiple sclerosis, Nat. Med., 6, 67, 10.1038/71555 Plaut, 1987, Effectiveness of amantadine in reducing relapses in multiple sclerosis, J. R. Soc. Med., 80, 91, 10.1177/014107688708000210 Prineas, 2002, Demyelinating diseases, 471 Reagan, 2004, Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine, Proc. Natl. Acad. Sci. U. S. A., 101, 2179, 10.1073/pnas.0307294101 Rothstein, 1994, Localization of neuronal and glial glutamate transporters, Neuron, 13, 713, 10.1016/0896-6273(94)90038-8 Sanchez-Gomez, 1999, AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures, Neurobiol. Dis., 6, 475, 10.1006/nbdi.1999.0264 Sanchez-Gomez, 2003, Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors, J. Neurosci., 23, 9519, 10.1523/JNEUROSCI.23-29-09519.2003 Sarchielli, 2003, Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid, Arch. Neurol., 60, 1082, 10.1001/archneur.60.8.1082 Smith, 1999, Demyelination: the role of reactive oxygen and nitrogen species, Brain Pathol., 9, 69, 10.1111/j.1750-3639.1999.tb00212.x Smith, 2000, Autoimmune encephalomyelitis ameliorated by AMPA antagonists, Nat. Med., 6, 62, 10.1038/71548 Srinivasan, 2005, Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T, Brain, 128, 1016, 10.1093/brain/awh467 Steinman, 2001, Multiple sclerosis: a two-stage disease, Nat. Immunol., 2, 762, 10.1038/ni0901-762 Steinman, 2002, Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy, Annu. Rev. Neurosci., 25, 491, 10.1146/annurev.neuro.25.112701.142913 Stover, 1997, Neurotransmitters in cerebrospinal fluid reflect pathological activity, Eur. J. Clin. Invest., 27, 1038, 10.1046/j.1365-2362.1997.2250774.x Tekkok, 2001, Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter, J. Neurosci., 21, 4237, 10.1523/JNEUROSCI.21-12-04237.2001 Thorlin, 1998, Regulation of the glial glutamate transporter GLT-1 by glutamate and delta-opioid receptor stimulation, FEBS Lett., 425, 453, 10.1016/S0014-5793(98)00288-9 Tourbah, 1999, Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis, Neurology, 53, 1091, 10.1212/WNL.53.5.1091 Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N. Engl. J. Med., 338, 278, 10.1056/NEJM199801293380502 Trotti, 1998, Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?, Trends Pharmacol. Sci., 19, 328, 10.1016/S0165-6147(98)01230-9 Vandesompele, 2002, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol., 3, 1, 10.1186/gb-2002-3-7-research0034 Van Landeghem, 2001, Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat, Glia, 35, 167, 10.1002/glia.1082 Vera-Portocarrero, 2002, Rapid changes in expression of glutamate transporters after spinal cord injury, Brain Res., 927, 104, 10.1016/S0006-8993(01)03329-7 Wallstrom, 1996, Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis, J. Neurol. Sci., 137, 89, 10.1016/0022-510X(95)00339-4 Weiner, 2002, Inflammation and therapeutic vaccination in CNS diseases, Nature, 420, 879, 10.1038/nature01325 Werner, 2001, Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage, Ann. Neurol., 50, 169, 10.1002/ana.1077 Westall, 1980, Abnormal glutamic acid metabolism in multiple sclerosis, J. Neurol. Sci., 47, 353, 10.1016/0022-510X(80)90088-X Westergren, 1994, Concentrations of amino acids in extracellular fluid after opening of the blood–brain barrier by intracarotid infusion of protamine sulfate, J. Neurochem., 62, 159, 10.1046/j.1471-4159.1994.62010159.x Wucherpfennig, 1997, Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR-2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes, J. Clin. Invest., 100, 1114, 10.1172/JCI119622